Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

30
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
30
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

8.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
The Thyroid Gland01:23

The Thyroid Gland

8.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myeloid sarcomas: Experience from a pediatric oncology referral center.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2026
Same author

Intestinal obstruction as a result of intra-abdominal hematoma: a complication of low molecular weight heparin in pediatric patients.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2024
Same author

Treatment of pectus excavatum with vacuum bell during puberty.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2023
Same author

Analysis of esthetic assessment scales in two surgical approaches for hypertrophic pyloric stenosis.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2023
Same author

Postoperative hyperlipasemia in perforated appendicitis in children.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2022
Same author

Evaluation of transjugular intrahepatic portosystemic shunt (TIPS) as a previous step to liver transplantation in pediatric patients.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2022

Related Experiment Video

Updated: Feb 23, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.0K

[Prophylactic thyroidectomy in RET proto-oncogen mutation].

L Rodríguez Caraballo1, J Gómez-Chacón Villalba1, P Rodríguez Iglesias1

  • 1Servicio de Cirugía Pediátrica. Hospital Politècnic y Universitari La Fe. Valencia.

Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica
|September 1, 2017
PubMed
Summary

Prophylactic thyroidectomy in children with RET gene mutations is crucial for early detection and prevention of medullary thyroid carcinoma. Early surgical intervention in experienced centers significantly reduces complications and ensures favorable outcomes.

Keywords:
Medullary thyroid carcinomaNEM2ANEM2BRETThyroidectomy

More Related Videos

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

657
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

1.6K

Related Experiment Videos

Last Updated: Feb 23, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.0K
Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

657
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

1.6K

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatric Surgery

Background:

  • RET proto-oncogene mutations are associated with an increased risk of medullary thyroid carcinoma (MTC).
  • Prophylactic thyroidectomy is recommended for individuals with identified RET mutations to prevent MTC development.

Purpose of the Study:

  • To analyze outcomes of prophylactic thyroidectomy in pediatric patients with RET gene mutations.
  • To evaluate the efficacy and safety of early surgical intervention for MTC prevention.

Main Methods:

  • Retrospective review of 25 pediatric patients undergoing prophylactic thyroidectomy for RET mutations (2000-2016).
  • Analysis included epidemiological data, surgical techniques, histological findings, and patient follow-up.

Main Results:

  • 16 out of 25 patients (64%) had MTC or precursor lesions at surgery.
  • All patients underwent total thyroidectomy without immediate complications.
  • Follow-up revealed normal biochemical markers in most patients, indicating successful intervention.

Conclusions:

  • RET gene analysis identifies pediatric patients requiring prophylactic thyroidectomy.
  • Early thyroidectomy in specialized centers is essential for managing MTC risk in these patients.